Status: Active
Endovascular Engineering
- Status Current
- Sector Aortic & Peripheral, Venous Thromboembolism
- Year Invested 2025
- HQ Menlo Park, CA, United States
- Clinical Operations United States
- Lead Partners Dr. Ruben Osnabrugge
Website endovascularengineering.com/
Next generation clot removal technologies that target venous thromboembolism
Endovascular Engineering has developed a next generation clot removal technology platform for venous thromboembolism (VTE). The Hēlo Thrombectomy System represents a breakthrough in clot removal technology, featuring a patented dual-action mechanism that integrates powerful aspiration with advanced mechanical clot disruption. The system delivers large-bore performance through a small-profile catheter, enabling efficient single-pass procedures